4-Chloropyrimidine → HCID 59239486, 화합물
반응식
[CH2:1]([NH:3][C:4]([NH:6][C:7]1[CH:12]=[CH:11][C:10]([C:13]2[N:14]=[C:15]([N:23]3[CH2:28][CH2:27][O:26][CH2:25][C@@H:24]3[CH3:29])[C:16]3[CH2:22][CH2:21][NH:20][CH2:19][C:17]=3[N:18]=2)=[CH:9][CH:8]=1)=[O:5])[CH3:2].Cl[C:31]1[CH:36]=[CH:35][N:34]=[CH:33][N:32]=1>>[CH2:1]([NH:3][C:4]([NH:6][C:7]1[CH:8]=[CH:9][C:10]([C:13]2[N:14]=[C:15]([N:23]3[CH2:28][CH2:27][O:26][CH2:25][C@@H:24]3[CH3:29])[C:16]3[CH2:22][CH2:21][N:20]([C:31]4[CH:36]=[CH:35][N:34]=[CH:33][N:32]=4)[CH2:19][C:17]=3[N:18]=2)=[CH:11][CH:12]=1)=[O:5])[CH3:2]참가 물질
3
실험 절차
Compound (dw) was prepared according to the procedure described in Example 2 by reacting (S)-1-ethyl-3-(4-(4-(3-methylmorpholino)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-2-yl)phenyl)urea with 4-chloropyrimidine. LC-MS: m/z=+475 (M+H)−.
후처리
- customCompound (dw) was prepared
출처 및 근거
- ORD 기록
- ord-7774ca615d934236bd77b5bb15a722b7
- 출처 데이터셋
- uspto-grants-2012_04
- 특허 번호
- US08163763B2
반응 노트
불러오는 중…